NK:IO: Funding, Investors & Team (Sep 2026)
NK:IO is a biotechnology firm that focuses on creating innovative methods for using natural killer cells in immunotherapy. They work on developing cell-based treatments and small molecule therapies that mainly aim at fighting cancer.
NK:IO has raised $1.5M across 1 funding round on record, the most recent a Seed of $1.5M announced in Jul 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NK:IO Company Profile and Key Stats
Latest funding round on record: Jul 2023.
NK:IO Funding Rounds
NK:IO Founders and Leadership Team
No contact details are on record for this team yet.
NK:IO Funding Compared to Other Biotechnology Startups
NK:IO's latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NK:IO in Biotechnology and London
Companies Similar to NK:IO
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
NK:IO Funding FAQs
What does NK:IO do?
NK:IO is a biotechnology firm that focuses on creating innovative methods for using natural killer cells in immunotherapy. They work on developing cell-based treatments and small molecule therapies that mainly aim at fighting cancer.
How much funding has NK:IO raised?
NK:IO has raised $1.5M across 1 round on record. The most recent is a Seed of $1.5M announced in Jul 2023.
When did NK:IO last raise funding?
NK:IO's most recent funding round on record is a Seed of $1.5M, announced in Jul 2023.
Who founded NK:IO?
FundedIQ lists Andrew Baxendale (Founder) at NK:IO.
Where is NK:IO headquartered?
NK:IO is based in London, England, United Kingdom.
How many employees does NK:IO have?
NK:IO is in the 11-50 employee band.
How does NK:IO's funding compare to other Biotechnology startups?
NK:IO's latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's NK:IO Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NK:IO is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.